Clinical Trial Update: Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim

View source ↗

Summary

This completed clinical trial investigated biomarkers in blood from patients with stage IV melanoma who had prior treatment with sargramostim.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Leukine (sargramostim)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Melanoma (Skin) | Status: COMPLETED